Activating STAT5b mutations have also been found in 55% of CD4+/CD8−/TCRαβ+ T-LGL leukemia patients but are very rare among patients with CD4−/CD8+ T-LGL leukemia or NK-LGL [74]. Here, STAT5B is linked to T-cell large granular lymphocyte leukemia.